Structures by: Male L.
Total: 229
C18H19NO2
C18H19NO2
Organic Chemistry Frontiers (2015) 2, 11 1445
a=7.63367(18)Å b=29.2305(5)Å c=6.84862(15)Å
α=90° β=102.295(2)° γ=90°
C16H17NO3
C16H17NO3
Organic Chemistry Frontiers (2015) 2, 11 1445
a=6.86998(8)Å b=15.21957(20)Å c=27.0563(4)Å
α=90° β=90° γ=90°
C18H20N2O3
C18H20N2O3
Organic Chemistry Frontiers (2015) 2, 11 1445
a=6.8071(3)Å b=15.0202(7)Å c=15.8559(8)Å
α=90.798(4)° β=101.156(4)° γ=100.035(4)°
C11H14N2O2
C11H14N2O2
Organic Chemistry Frontiers (2015) 2, 11 1445
a=7.5414(3)Å b=11.8446(5)Å c=12.2635(5)Å
α=80.154(4)° β=88.093(4)° γ=88.519(3)°
C46H42N2O
C46H42N2O
Organic Chemistry Frontiers (2015) 2, 11 1445
a=12.55604(14)Å b=15.09459(13)Å c=18.96430(17)Å
α=90° β=105.8657(10)° γ=90°
C48H46N2O3
C48H46N2O3
Organic Chemistry Frontiers (2015) 2, 11 1445
a=10.1705(3)Å b=10.2903(3)Å c=19.4528(5)Å
α=99.778(2)° β=99.679(2)° γ=106.888(2)°
C34H34N2O
C34H34N2O
Organic Chemistry Frontiers (2015) 2, 11 1445
a=11.9986(2)Å b=10.60180(16)Å c=20.9045(4)Å
α=90° β=104.8514(19)° γ=90°
C29H26N2O4,0.5(C3H8O)
C29H26N2O4,0.5(C3H8O)
Organic letters (2017) 19, 6 1338-1341
a=8.73850(10)Å b=8.77985(12)Å c=65.4284(6)Å
α=90° β=90° γ=90°
IrPyr
C59H42IrN4,F6P,4(CHCl3)
The Analyst (2016) 141, 10 3090-3097
a=19.7764(14)Å b=17.2133(11)Å c=20.4799(14)Å
α=90° β=115.774(2)° γ=90°
IrbisPyr
C76H52IrN4,F6P,1.25(CH2Cl2)
The Analyst (2016) 141, 10 3090-3097
a=13.1487(9)Å b=23.0231(16)Å c=23.3516(16)Å
α=67.2098(19)° β=75.538(2)° γ=78.319(2)°
C21H28N2O2Si2
C21H28N2O2Si2
Crystal Structure Report Archive (2007) 333
a=10.72290(10)Å b=10.23950(10)Å c=20.1530(2)Å
α=90.00° β=92.7121(7)° γ=90.00°
C29H31BFeN,C16H36N,CDCl3
C29H31BFeN,C16H36N,CDCl3
Crystal Structure Report Archive (2007) 338
a=11.9359(3)Å b=17.2845(5)Å c=21.4406(6)Å
α=90.00° β=92.581(2)° γ=90.00°
C17H20ClFeNO3
C17H20ClFeNO3
Crystal Structure Report Archive (2007) 340
a=7.8204(2)Å b=19.1689(6)Å c=11.3839(3)Å
α=90.00° β=100.727(2)° γ=90.00°
C12H8FeN2
C12H8FeN2
Crystal Structure Report Archive (2007) 341
a=6.5148(3)Å b=11.4581(5)Å c=6.8511(2)Å
α=90.00° β=111.601(2)° γ=90.00°
C19H28ClNO2S
C19H28ClNO2S
Crystal Structure Report Archive (2007) 332
a=15.4076(3)Å b=12.9924(4)Å c=9.3800(3)Å
α=90.00° β=90.00° γ=90.00°
C16H26N2O3Si2,Cl2
C16H26N2O3Si2,Cl2
Crystal Structure Report Archive (2007) 330
a=7.14930(10)Å b=18.6099(6)Å c=8.8649(2)Å
α=90.00° β=113.221(2)° γ=90.00°
C18H34P,C9H7GaI3MoO2
C18H34P,C9H7GaI3MoO2
Crystal Structure Report Archive (2007) 339
a=9.2979(5)Å b=18.4632(8)Å c=18.9798(9)Å
α=90.00° β=99.325(3)° γ=90.00°
C13H21NO2Si
C13H21NO2Si
Crystal Structure Report Archive (2007) 331
a=7.23190(10)Å b=11.0720(3)Å c=18.1646(5)Å
α=90.00° β=90.00° γ=90.00°
C20H40N8O4,2(CH4O)
C20H40N8O4,2(CH4O)
Crystal Structure Report Archive (2007) 334
a=8.8971(4)Å b=9.5970(4)Å c=9.8882(3)Å
α=64.918(2)° β=81.546(2)° γ=68.435(2)°
C14H15NO
C14H15NO
Crystal Structure Report Archive (2007) 351
a=5.37320(10)Å b=13.4962(4)Å c=15.8088(5)Å
α=95.3890(10)° β=98.498(2)° γ=101.201(2)°
C11H11NO
C11H11NO
Crystal Structure Report Archive (2007) 348
a=9.7504(3)Å b=10.2281(3)Å c=14.0530(5)Å
α=95.766(2)° β=107.842(2)° γ=96.617(2)°
1,4-dibenzyl-6-(3-(2-bromophenyl)-3-oxo-1-phenylpropyl)piperazine-2,3,5-trione
C33H27BrN2O4
Chem. Sci. (2015) 6, 2 1350
a=9.71430(10)Å b=22.59340(10)Å c=12.66410(10)Å
α=90° β=106.7030(10)° γ=90°
1,4-dibenzyl-6-(3-oxo-1,3-diphenylpropyl)piperazine-2,3,5-trione
C33H28N2O4
Chem. Sci. (2015) 6, 2 1350
a=12.1648(1)Å b=12.4912(1)Å c=17.1070(2)Å
α=90° β=90° γ=90°
1,4-dibenzyl-6-(2-(2-methyl-1,3-dioxolan-2-yl)ethyl)piperazine-2,3,5-trione
C24H26N2O5
Chem. Sci. (2015) 6, 2 1350
a=6.25441(12)Å b=12.5920(2)Å c=13.61853(18)Å
α=100.7552(12)° β=92.7028(13)° γ=95.0674(14)°
C22H22N2O5
C22H22N2O5
Chem. Sci. (2015) 6, 2 1350
a=12.14306(17)Å b=6.28576(7)Å c=13.0165(2)Å
α=90° β=108.5659(17)° γ=90°
C36H40B4Fe2O8
C36H40B4Fe2O8
Crystal Structure Report Archive (2006) 329
a=19.6222(11)Å b=7.8609(3)Å c=21.3982(11)Å
α=90.00° β=90.00° γ=90.00°
C40H52NNiS4
C40H52NNiS4
Crystal Structure Report Archive (2006) 232
a=12.113(5)Å b=16.307(6)Å c=19.257(8)Å
α=90.00° β=90.00° γ=90.00°
C18H11ClFeN2
C18H11ClFeN2
Crystal Structure Report Archive (2007) 105
a=7.3730(5)Å b=13.2476(10)Å c=30.324(2)Å
α=90.00° β=93.123(4)° γ=90.00°
C11H14N2O
C11H14N2O
Crystal Structure Report Archive (2007) 337
a=11.9613(5)Å b=6.6856(2)Å c=13.4450(4)Å
α=90.00° β=106.263(2)° γ=90.00°
C7H5NO5
C7H5NO5
Crystal Structure Report Archive (2007) 343
a=5.1231(2)Å b=8.7759(3)Å c=9.2683(3)Å
α=62.246(2)° β=75.259(2)° γ=82.642(2)°
C18H20IN
C18H20IN
Organic letters (2010) 12, 21 5044-5047
a=6.9828(2)Å b=9.0924(5)Å c=25.8129(12)Å
α=90.00° β=93.829(3)° γ=90.00°
C18H20INO
C18H20INO
Organic letters (2010) 12, 21 5044-5047
a=10.6159(3)Å b=12.3314(3)Å c=13.4921(3)Å
α=81.7569(15)° β=74.4479(14)° γ=81.2906(14)°
C14H17NO4
C14H17NO4
Organic letters (2012) 14, 9 2234-2237
a=6.0349(17)Å b=6.944(2)Å c=29.781(9)Å
α=90.00° β=95.570(11)° γ=90.00°
C14H15NO5S
C14H15NO5S
Organic letters (2012) 14, 9 2234-2237
a=16.1951(4)Å b=7.5226(3)Å c=23.5755(9)Å
α=90.00° β=107.623(2)° γ=90.00°
C14H15NO2
C14H15NO2
Organic letters (2012) 14, 9 2234-2237
a=9.0675(3)Å b=6.0052(2)Å c=21.3783(8)Å
α=90.00° β=98.657(2)° γ=90.00°
C14H15NO5S
C14H15NO5S
Organic letters (2012) 14, 9 2234-2237
a=11.0852(2)Å b=7.98040(10)Å c=31.3518(5)Å
α=90.00° β=90.00° γ=90.00°
C20H28N2O2S2
C20H28N2O2S2
Organic letters (2012) 14, 9 2234-2237
a=6.3563(16)Å b=7.9604(13)Å c=20.414(4)Å
α=87.759(12)° β=89.300(18)° γ=74.762(18)°
C19H32N2O5Si2
C19H32N2O5Si2
Organic letters (2008) 10, 21 4747-4750
a=15.8689(8)Å b=6.8068(3)Å c=21.1152(8)Å
α=90.00° β=92.689(3)° γ=90.00°
C12H18O3
C12H18O3
Organic & biomolecular chemistry (2012) 10, 25 4926-4932
a=7.106(3)Å b=14.861(3)Å c=11.691(3)Å
α=90.00° β=101.499(16)° γ=90.00°
C13H18O4S
C13H18O4S
Organic & biomolecular chemistry (2012) 10, 25 4926-4932
a=10.05890(10)Å b=10.53230(10)Å c=12.30560(10)Å
α=90.00° β=100.6460(10)° γ=90.00°
2-hydroxynaphtho(1,8-de)(1,3,2)dithiazine 1,1,3,3-tetraoxide monohydrate
C10H7NO5S2,H2O
Organic & biomolecular chemistry (2011) 9, 7 2336-2344
a=6.9698(2)Å b=9.4671(3)Å c=17.7500(4)Å
α=90.00° β=94.399(2)° γ=90.00°
(Z)-1,1,3,3-tetraoxidonaphtho(1,8-d,e)(1,3,2)dithiazin-2-yl N- (2-cyanopropan-2-yl)isobutyimidate
C18H19N3O5S2
Organic & biomolecular chemistry (2011) 9, 7 2336-2344
a=15.1983(15)Å b=8.5889(7)Å c=15.6813(15)Å
α=90.00° β=95.420(10)° γ=90.00°
2-hydroxynaphtho(1,8-de)(1,3,2)dithiazine 1,1,3,3-tetraoxide ethyl acetate
C10H7NO5S2,C4H8O2
Organic & biomolecular chemistry (2011) 9, 7 2336-2344
a=14.1894(3)Å b=7.1236(2)Å c=18.0588(4)Å
α=90.00° β=112.6270(10)° γ=90.00°
N-hydroxy-O-benzenedisulfonimide monohydrate
C6H5NO5S2,H2O
Organic & biomolecular chemistry (2011) 9, 7 2336-2344
a=7.2877(3)Å b=8.1680(3)Å c=8.3571(2)Å
α=93.740(2)° β=107.823(2)° γ=92.785(2)°
4-butyl-2-hydroxynaphtho(1,8-de)(1,3,2)dithiazine 1,1,3,3- tetraoxide monohydrate
C14H15NO5S2,H2O
Organic & biomolecular chemistry (2011) 9, 7 2336-2344
a=12.0422(14)Å b=13.3971(13)Å c=21.306(3)Å
α=72.268(7)° β=81.717(4)° γ=74.535(7)°
5,6-Dibromo-1H-indole
C8H5Br2N
Organic & biomolecular chemistry (2011) 9, 14 5021-5023
a=11.0874(6)Å b=7.5403(4)Å c=18.8720(10)Å
α=90.00° β=90.00° γ=90.00°
Methyl 5,6-dibromo-1H-indole-3-carboxylate
C10H7Br2NO2
Organic & biomolecular chemistry (2011) 9, 14 5021-5023
a=7.1280(4)Å b=7.3609(4)Å c=10.9238(6)Å
α=90.492(3)° β=98.609(3)° γ=112.463(3)°
3,5,6-Tribromo-1H-indole
C8H4Br3N
Organic & biomolecular chemistry (2011) 9, 14 5021-5023
a=8.8688(4)Å b=6.0886(3)Å c=16.8852(8)Å
α=90.00° β=91.443(3)° γ=90.00°
3,5,6-Tribromo-N-methyl-1H-indole
C9H6Br3N
Organic & biomolecular chemistry (2011) 9, 14 5021-5023
a=7.6033(4)Å b=8.0327(4)Å c=9.6610(5)Å
α=68.061(3)° β=66.835(3)° γ=73.873(3)°
C21H25N3O2
C21H25N3O2
Organic & biomolecular chemistry (2013) 11, 30 4957-4970
a=11.25880(10)Å b=11.7630(2)Å c=12.8358(2)Å
α=90.00° β=90.00° γ=90.00°
C40H45N3O5S,CH4O
C40H45N3O5S,CH4O
Organic & biomolecular chemistry (2013) 11, 30 4957-4970
a=10.6567(3)Å b=13.9156(4)Å c=24.7451(6)Å
α=90.00° β=90.00° γ=90.00°
C24H23N5,0.5(CHCl3)
C24H23N5,0.5(CHCl3)
Organic & biomolecular chemistry (2013) 11, 31 5083-5093
a=5.8473(6)Å b=36.267(4)Å c=20.608(2)Å
α=90.00° β=92.220(4)° γ=90.00°
C21H26N2O3Ru,C2H3N
C21H26N2O3Ru,C2H3N
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1181-1190
a=12.1133(5)Å b=12.9420(7)Å c=15.0302(8)Å
α=70.115(5)° β=84.171(4)° γ=84.068(4)°
C17H18N2O2Ru
C17H18N2O2Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1181-1190
a=5.9641(4)Å b=8.3166(7)Å c=15.9058(16)Å
α=98.820(7)° β=95.605(6)° γ=104.953(6)°
C14H19NRu
C14H19NRu
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1181-1190
a=7.6382(3)Å b=20.2298(9)Å c=8.0749(3)Å
α=90° β=99.314(4)° γ=90°
C12H12Ru
C12H12Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1181-1190
a=11.9888(12)Å b=5.6864(5)Å c=14.2237(16)Å
α=90° β=100.876(9)° γ=90°
C12H14ORu
C12H14ORu
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1181-1190
a=30.3009(5)Å b=30.3009(5)Å c=5.97018(11)Å
α=90° β=90° γ=120°
C12H27N1O3S1
C12H27N1O3S1
Chemical Communications (2019)
a=14.3352(2)Å b=14.3352(2)Å c=12.2455(2)Å
α=90° β=90° γ=120°
C33H31F4IrN2O4,0.5(CH2Cl2)
C33H31F4IrN2O4,0.5(CH2Cl2)
Journal of Materials Chemistry C (2016) 4, 3738-3746
a=13.2592(3)Å b=17.0439(4)Å c=17.1957(4)Å
α=113.094(2)° β=105.6129(19)° γ=99.0525(18)°
C34H28F4IrN3O4,2(CHCl3)
C34H28F4IrN3O4,2(CHCl3)
Journal of Materials Chemistry C (2016) 4, 3738-3746
a=11.2797(2)Å b=31.1640(5)Å c=11.8865(2)Å
α=90° β=111.640(2)° γ=90°
C36H42B2N6O4
C36H42B2N6O4
Chemical communications (Cambridge, England) (2017) 53, 14 2218-2221
a=6.27417(14)Å b=21.9593(5)Å c=12.6125(3)Å
α=90° β=96.237(2)° γ=90°
C36H42B2N6O4
C36H42B2N6O4
Chemical communications (Cambridge, England) (2017) 53, 14 2218-2221
a=16.3223(5)Å b=12.4005(4)Å c=17.5981(5)Å
α=90° β=103.806(3)° γ=90°
C36H42B2N6O4
C36H42B2N6O4
Chemical communications (Cambridge, England) (2017) 53, 14 2218-2221
a=26.0090(3)Å b=6.56488(9)Å c=20.4434(3)Å
α=90° β=90° γ=90°
Bis(S-N-(1-phenylethyl)-2,5-dihdyropyrrolo)tetrathiafulvalene
C26H26N2S4
CrystEngComm (2009) 11, 6 993
a=5.9951(12)Å b=6.5877(13)Å c=15.830(3)Å
α=86.69(3)° β=83.08(3)° γ=76.01(3)°
Bis(R-N-(1-naphthyl)ethyl-2,5-dihydropyrrolo)tetrathiafulvalene
C34H30N2S4
CrystEngComm (2009) 11, 6 993
a=12.705(3)Å b=6.1713(12)Å c=19.492(4)Å
α=90.00° β=108.72(3)° γ=90.00°
Bis(S-N-(1-phenylethyl)pyrrolo)tetrathiafulvalene
C26H22N2S4
CrystEngComm (2009) 11, 6 993
a=7.4847(4)Å b=7.4847(4)Å c=42.565(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(R-N-(1-naphthyl)ethylpyrrolo)tetrathiafulvalene
C34H26N2S4
CrystEngComm (2009) 11, 6 993
a=10.8652(2)Å b=10.8969(2)Å c=47.0032(10)Å
α=90.00° β=90.00° γ=90.00°
1-H-Tetrazole, 1-(Phenylmethyl)
C8H8N4
CrystEngComm (2012) 14, 20 6441
a=7.6843(5)Å b=5.5794(4)Å c=9.4459(7)Å
α=90.00° β=100.949(4)° γ=90.00°
Isonicotinamide:azelaic acid
C9H16O4,C6H6N2O
CrystEngComm (2011) 13, 12 4188
a=8.2118(11)Å b=5.0680(7)Å c=38.683(5)Å
α=90.00° β=93.264(6)° γ=90.00°
Isonicotinamide:pimelic acid
C7H12O4,C6H6N2O
CrystEngComm (2011) 13, 12 4188
a=8.2223(5)Å b=5.1437(3)Å c=33.389(2)Å
α=90.00° β=93.873(3)° γ=90.00°
Isonicotinamide:suberic acid
C8H14O4,C6H6N2O
CrystEngComm (2011) 13, 12 4188
a=8.9413(15)Å b=9.5366(13)Å c=10.1347(17)Å
α=86.653(11)° β=66.031(7)° γ=66.571(10)°
Benzothiazolium tetrachloroaurate(iii)
C7H6NS,AuCl4
Dalton Transactions (2009) 47 10446-10456
a=15.3524(4)Å b=7.7452(2)Å c=19.3505(3)Å
α=90.00° β=90.00° γ=90.00°
5-Ethoxy-benzimidazolium oxonium dichloride tetrachloroaurate(iii) pentahydrate
4(C9H10N2O),AUCL4,4CL,5(OH2),0H3
Dalton Transactions (2009) 47 10446-10456
a=22.0808(5)Å b=25.1431(7)Å c=4.87740(10)Å
α=90.00° β=92.500(2)° γ=90.00°
C25H19AuNPS2
C25H19AuNPS2
Dalton Transactions (2009) 47 10446-10456
a=12.7430(9)Å b=12.9378(7)Å c=13.6063(6)Å
α=90.00° β=95.993(5)° γ=90.00°
C18H15AuClP
C18H15AuClP
Dalton Transactions (2009) 47 10446-10456
a=10.1850(10)Å b=12.3820(10)Å c=13.1070(10)Å
α=90.00° β=90.00° γ=90.00°
C6H5NO5S
C6H5NO5S
Dalton Transactions (2009) 47 10446-10456
a=6.7620(10)Å b=7.8400(10)Å c=8.7970(10)Å
α=63.610(10)° β=85.350(10)° γ=65.390(10)°
C21H19AuNPS2
C21H19AuNPS2
Dalton Transactions (2009) 47 10446-10456
a=8.8350(10)Å b=10.9260(10)Å c=11.426(2)Å
α=87.140(10)° β=87.720(10)° γ=75.210(10)°
(Pd2L2(m-dppe)Cl2) where LH=1-methyl-5-phenyl-1H-1,4- benzodiazepin-2(3H)-one
C58H50Cl2N4O2P2Pd2,4(C1H1Cl3)
Dalton Transactions (2009) 22 4299-4303
a=11.3456(5)Å b=10.9170(4)Å c=27.5717(11)Å
α=90.00° β=97.760(2)° γ=90.00°
(E)-3-Ferrocenylmethylidene-1,3-dihydro-2H-indol-2-one
C19H15FeNO
Dalton Transactions (2009) 6 918-921
a=5.93060(10)Å b=13.5489(4)Å c=19.0452(5)Å
α=73.8463(13)° β=85.2798(15)° γ=86.0675(13)°
(Z)-3-Ferrocenylmethylidene-1,3-dihydro-2H-indol-2-one
C19H15FeNO
Dalton Transactions (2009) 6 918-921
a=15.1939(14)Å b=6.1825(6)Å c=15.4621(14)Å
α=90.00° β=93.168(5)° γ=90.00°
4-nonafluorophenyltrimethyltin
C15H9F9Sn
Dalton Transactions (2009) 9 1593-1601
a=6.7641(4)Å b=11.2250(8)Å c=11.2842(8)Å
α=66.841(7)° β=83.121(6)° γ=81.090(6)°
Nonafluorobiphenyl dimethyl tin bromide acetonitrile solvate
C14H6BrF9Sn,C2H3N
Dalton Transactions (2009) 9 1593-1601
a=9.8151(2)Å b=10.5666(3)Å c=18.0686(4)Å
α=90.00° β=96.468(2)° γ=90.00°
Bis(pentafluorophenyl)(nonfluorobiphenyl)boron acetonitrile, acetonitrile solvate
C26H3BF19N,C2H3N
Dalton Transactions (2009) 9 1593-1601
a=10.1502(4)Å b=9.9420(3)Å c=27.4704(11)Å
α=90.00° β=99.069(4)° γ=90.00°
Bis(4-nonafluorobiphenyl)bis(diethylether) zinc
C32H20F18O2Zn
Dalton Transactions (2009) 9 1593-1601
a=19.078(4)Å b=8.1176(8)Å c=20.494(3)Å
α=90.00° β=91.363(14)° γ=90.00°
Bis(4-nonafluorobiphenyl)boronic acid hydrate
C24H3BF18O2,3(C6D6)
Dalton Transactions (2009) 9 1593-1601
a=7.0808(2)Å b=14.5619(7)Å c=18.4705(8)Å
α=92.210(2)° β=95.502(3)° γ=99.797(2)°
(C6F5)3BNH3.2(C5H5N)
C18H3BF15N,2(C5H5N)
Dalton Transactions (2008) 45 6381-6392
a=9.9845(14)Å b=25.873(2)Å c=10.7558(11)Å
α=90.00° β=105.237(9)° γ=90.00°
AnnaF4
C18H3BF15N,C2H3N
Dalton Transactions (2008) 45 6381-6392
a=9.2789(7)Å b=9.9867(6)Å c=11.7257(10)Å
α=101.070(7)° β=100.590(7)° γ=103.133(6)°
AnnaF24
C18H3BF15N,3(C4H8O),C4.655
Dalton Transactions (2008) 45 6381-6392
a=15.1659(11)Å b=15.1659(11)Å c=26.9397(3)Å
α=90.00° β=90.00° γ=120.00°
AnnaF1
2(C18H3BF15N),3(C4H4N2)
Dalton Transactions (2008) 45 6381-6392
a=7.8554(5)Å b=36.146(3)Å c=9.0775(4)Å
α=90.00° β=105.391(5)° γ=90.00°
AnnaF1a
C18H3BF15N,C4H4N2,CH2Cl2
Dalton Transactions (2008) 45 6381-6392
a=7.7724(9)Å b=29.639(3)Å c=11.8275(7)Å
α=90.00° β=110.192(8)° γ=90.00°
AnnaF7
2(C18H3BF15N1),C10H8N2
Dalton Transactions (2008) 45 6381-6392
a=10.5017(18)Å b=11.412(5)Å c=11.547(3)Å
α=96.404(5)° β=111.114(19)° γ=115.928(10)°
AnnaF5
2(C18H3BF15N),2(C6H12N2),2(CH2Cl2)
Dalton Transactions (2008) 45 6381-6392
a=17.9464(3)Å b=16.8703(4)Å c=19.6562(3)Å
α=90.00° β=106.4170(11)° γ=90.00°
2005SRC0307
C18H3BF15N,C10H20O5,C0.5HCl
Dalton Transactions (2008) 45 6381-6392
a=10.5169(8)Å b=12.1454(6)Å c=12.4667(7)Å
α=84.845(4)° β=83.918(4)° γ=82.348(5)°
AnnaF13a
C18H3BF15N,C15H12N3,C0.5HCl
Dalton Transactions (2008) 45 6381-6392
a=20.5853(16)Å b=16.0102(10)Å c=22.0129(11)Å
α=90.00° β=114.527(7)° γ=90.00°
C36H40B4Fe2O8
C36H40B4Fe2O8
Dalton transactions (Cambridge, England : 2003) (2007) 32 3486-3488
a=19.6222(11)Å b=7.8609(3)Å c=21.3982(11)Å
α=90.00° β=90.00° γ=90.00°
C28H30B2Fe2O4
C28H30B2Fe2O4
Dalton transactions (Cambridge, England : 2003) (2007) 32 3486-3488
a=29.8942(10)Å b=10.7482(3)Å c=7.4301(3)Å
α=90.00° β=90.00° γ=90.00°
Sa0613
C1H1CL3
Dalton transactions (Cambridge, England : 2003) (2007) 32 3486-3488
a=16.7826(3)Å b=9.9148(2)Å c=20.8325(4)Å
α=90.00° β=108.3390(10)° γ=90.00°
C21H25N3O2,CH4O
C21H25N3O2,CH4O
Organic & biomolecular chemistry (2013) 11, 30 4957-4970
a=8.0470(17)Å b=10.678(3)Å c=22.331(5)Å
α=90.00° β=90.00° γ=90.00°
C16H19IO2Ru
C16H19IO2Ru
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1181-1190
a=8.1567(5)Å b=10.1040(7)Å c=10.3448(7)Å
α=111.683(7)° β=91.422(6)° γ=93.468(5)°
C25H18AuClNPS2
C25H18AuClNPS2
Dalton Transactions (2009) 47 10446-10456
a=8.8981(4)Å b=11.0221(4)Å c=14.1845(6)Å
α=89.145(3)° β=76.610(4)° γ=83.837(4)°